Does Zepbound Cause Acid Reflux?
Zepbound (tirzepatide), a GLP-1/GIP receptor agonist for weight loss, lists gastroesophageal reflux disease (GERD) or worsening GERD as a possible side effect in its prescribing information. Clinical trials reported GERD in up to 3.5% of patients on the highest dose (15 mg), compared to 1.8% on placebo.[1] Real-world patient reports on forums like Reddit and Drugs.com frequently mention heartburn, acid reflux, or regurgitation starting within weeks of use, often linked to slowed gastric emptying.
Why Does It Happen with Zepbound?
Tirzepatide delays stomach emptying, which can relax the lower esophageal sphincter and allow acid to reflux upward. This effect is dose-dependent and more common in the first 4-8 weeks as the body adjusts.[1][2] Obesity itself increases GERD risk, so some cases may reflect underlying conditions amplified by the drug.
How Common Is Acid Reflux Compared to Similar Drugs?
| Drug | GERD Incidence (Trials) | Notes |
|------|--------------------------|-------|
| Zepbound (15 mg) | 3.5% | Similar to Mounjaro; higher than placebo |
| Wegovy (semaglutide 2.4 mg) | 2-5% | Slightly lower reported rates |
| Ozempic (semaglutide 1 mg) | 1-3% | Dose-related |
Patients switching from semaglutide often report similar or slightly worse reflux with Zepbound due to dual GLP-1/GIP action.[3]
How Long Does Acid Reflux Last and What Helps?
Symptoms peak early and often improve after 1-3 months for many, but persist in 10-20% of users.[2] Management includes:
- Taking Zepbound with food or at bedtime to minimize peaks.
- OTC antacids (e.g., Tums), H2 blockers (Pepcid), or PPIs (omeprazole) as needed—prescribing info advises caution with PPIs due to interaction risks.
- Elevating bed head, avoiding late meals, and dose titration under doctor guidance.
If severe, pausing or switching doses resolves it in most cases.[1]
When to See a Doctor About Reflux on Zepbound
Contact a provider if reflux includes chest pain, difficulty swallowing, vomiting blood, or weight loss beyond expected. Rare cases link to gastroparesis or esophageal injury. Those with pre-existing GERD face higher risk and may need pre-treatment evaluation.[1][2]
[1]: Zepbound Prescribing Information, Eli Lilly (https://pi.lilly.com/us/zepbound-uspi.pdf)
[2]: SURMOUNT-1 Trial Data, NEJM (https://www.nejm.org/doi/full/10.1056/NEJMoa2206038)
[3]: FDA Adverse Event Reporting System (FAERS) summaries via Drugs.com (https://www.drugs.com/sfx/zepbound-side-effects.html)